OncoCyte OCX Stock
OncoCyte Price Chart
OncoCyte OCX Financial and Trading Overview
| OncoCyte stock price | 2.84 USD |
| Previous Close | 0.22 USD |
| Open | 0.22 USD |
| Bid | 0 USD x 1100 |
| Ask | 0 USD x 800 |
| Day's Range | 0.21 - 0.22 USD |
| 52 Week Range | 0.2 - 1.12 USD |
| Volume | 192.19K USD |
| Avg. Volume | 359.99K USD |
| Market Cap | 35.44M USD |
| Beta (5Y Monthly) | 1.58345 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -4.66 USD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 0.35 USD |
OCX Valuation Measures
| Enterprise Value | 31.94M USD |
| Trailing P/E | N/A |
| Forward P/E | -1.34375 |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 40.49887 |
| Price/Book (mrq) | 0.6761007 |
| Enterprise Value/Revenue | 36.5 |
| Enterprise Value/EBITDA | -1.394 |
Trading Information
OncoCyte Stock Price History
| Beta (5Y Monthly) | 1.58345 |
| 52-Week Change | -77.72% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 1.12 USD |
| 52 Week Low | 0.2 USD |
| 50-Day Moving Average | 0.26 USD |
| 200-Day Moving Average | 0.45 USD |
OCX Share Statistics
| Avg. Volume (3 month) | 359.99K USD |
| Avg. Daily Volume (10-Days) | 241.95K USD |
| Shares Outstanding | 164.82M |
| Float | 88.65M |
| Short Ratio | 6.1 |
| % Held by Insiders | 7.86% |
| % Held by Institutions | 81.55% |
| Shares Short | 1.42M |
| Short % of Float | 1.60% |
| Short % of Shares Outstanding | 0.85% |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2022 |
| Most Recent Quarter (mrq) | March 31, 2023 |
| Next Fiscal Year End | December 31, 2023 |
Profitability
| Profit Margin | 0% |
| Operating Margin (ttm) | -3129.37% |
| Gross Margin | -18.85% |
| EBITDA Margin | 0% |
Management Effectiveness
| Return on Assets (ttm) | -14.94% |
| Return on Equity (ttm) | -18.40% |
Income Statement
| Revenue (ttm) | 875K USD |
| Revenue Per Share (ttm) | 0.007 USD |
| Quarterly Revenue Growth (yoy) | -21.80% |
| Gross Profit (ttm) | N/A |
| EBITDA | -22905000 USD |
| Net Income Avi to Common (ttm) | -10820000 USD |
| Diluted EPS (ttm) | -0.09 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 12.36M USD |
| Total Cash Per Share (mrq) | 0.08 USD |
| Total Debt (mrq) | 3.33M USD |
| Total Debt/Equity (mrq) | 7.65 USD |
| Current Ratio (mrq) | 1.659 |
| Book Value Per Share (mrq) | 0.318 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -41963000 USD |
| Levered Free Cash Flow (ttm) | -12704375 USD |
Profile of OncoCyte
| Country | United States |
| State | CA |
| City | Irvine |
| Address | 15 Cushing |
| ZIP | 92618 |
| Phone | 949 409 7600 |
| Website | https://oncocyte.com |
| Industry | Diagnostics & Research |
| Sector(s) | Healthcare |
| Full Time Employees | 75 |
OncoCyte Corporation, a molecular diagnostics company, research, develops, and commercializes proprietary laboratory-developed tests for the detection of cancer in the United States and internationally. The company offers DetermaRx, a molecular test for early-stage adenocarcinoma of the lung; and DetermaIO, a proprietary gene expression assay. It also provides biomarker discovery testing, assay design and development, biopharma, and clinical trial support services, as well as various biomarker tests for pharmaceutical companies. The company has a collaboration agreement with Life Technologies Corporation to develop and collaborate in the commercialization of Oncomine Comprehensive Assay Plus and Determa IO assay for use with Ion Torrent Genexus integrated sequencer and purification system. OncoCyte Corporation was incorporated in 2009 and is based in Irvine, California.
Q&A For OncoCyte Stock
What is a current OCX stock price?
OncoCyte OCX stock price today per share is 2.84 USD.
How to purchase OncoCyte stock?
You can buy OCX shares on the NasdaqCM exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for OncoCyte?
The stock symbol or ticker of OncoCyte is OCX.
Which industry does the OncoCyte company belong to?
The OncoCyte industry is Diagnostics & Research.
How many shares does OncoCyte have in circulation?
The max supply of OncoCyte shares is 28.6M.
What is OncoCyte Price to Earnings Ratio (PE Ratio)?
OncoCyte PE Ratio is now.
What was OncoCyte earnings per share over the trailing 12 months (TTM)?
OncoCyte EPS is -4.66 USD over the trailing 12 months.
Which sector does the OncoCyte company belong to?
The OncoCyte sector is Healthcare.
OncoCyte OCX included in indexes
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume |
|---|
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume | |
|---|---|---|---|---|---|---|---|
| {{ item.name }} {{ item.symbol }} | {{ item.price }} {{ item.price_usd }} |
{{ item.change_pct }}
|
{{ item.volume }} {{ item.volume_usd }} | {{ item.low }} {{ item.low_usd }} | {{ item.high }} {{ item.high_usd }} | {{ item.components_count }} - | {{ item.volume }} {{ item.volume_usd }} |
| NASDAQ Composite IXIC | 15603.26 USD — |
+0.1
|
10.08B USD — | 14784.03 USD — | 16292.28 USD — | — - | 10.08B USD — |
| NASDAQ DM Ind Goods & Svcs Lg M NQDM2700LMT | 1757.5 USD — |
<0.01
|
— — | 1752.33 USD — | 1774.66 USD — | — - | — — |
| Stlmt ID NASDAQ Biotechnology NBX | 4153.28 USD — |
+1.21
|
— — | 4281.91 USD — | 4648.11 USD — | — - | — — |
| NASDAQ Global Market Composite NQGM | 1638.71 USD — |
-0.55
|
— — | 1547.55 USD — | 1705.12 USD — | — - | — — |
| NASDAQ DM Ind Goods & Svcs Lg M NQDM2700LMJPYT | 1761.11 JPY 11.89 USD |
<0.01
|
— — | 1761.11 JPY 11.89 USD | 1761.11 JPY 11.89 USD | — - | — — |
| NASDAQ Biotechnology NBI | 3856.67 USD — |
-1.22
|
— — | 3700.88 USD — | 3966.57 USD — | — - | — — |
| NASDAQ HealthCare IXHC | 865.57 USD — |
-0.49
|
— — | 828.4 USD — | 890 USD — | — - | — — |
- {{ link.label }} {{link}}